Coya Therapeutics, Inc. (COYA)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Coya Therapeutics, Inc. reported revenue of $7.95M, up 123.6% from the prior year. The company ran a net loss, with a net margin of -267.1%. It held $49.95M in total assets against $6.92M in total liabilities.
Key ratios (FY2025)
-283.9%
Operating margin
-267.1%
Net margin
-49.3%
Return on equity
+123.6%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue | $7.95M | $3.55M | $6.00M | $0 | — | — |
| Operating Income | -$22.56M | -$17.25M | -$7.90M | -$9.81M | -$4.87M | — |
| Net Income | -$21.23M | -$14.88M | -$7.99M | -$12.24M | -$4.89M | — |
| EPS (Diluted) | $-1.27 | $-0.98 | $-0.79 | $-4.73 | $-1.89 | — |
| Total Assets | $49.95M | $44.35M | $41.26M | $8.40M | $4.79M | — |
| Total Liabilities | $6.92M | $4.77M | $5.63M | $16.79M | $1.15M | — |
| Shareholders' Equity | $43.03M | $39.58M | $35.64M | -$8.39M | $3.64M | $8.30M |
| Cash & Equivalents | $46.82M | $38.34M | $32.63M | $5.93M | $4.34M | — |
| Operating Cash Flow | -$10.74M | -$10.29M | -$11.19M | -$7.24M | -$3.90M | — |
| Shares Outstanding | 20.93M | 16.71M | 14.41M | 2.59M | 2.59M | — |